Your browser doesn't support javascript.
loading
Attitudes and trends in the use of radiolucent spinal implants: A survey of the North American Spine Society section of spinal oncology.
Zavras, Athan G; Schoenfeld, Andrew J; Patt, Joshua C; Munim, Mohammed A; Goodwin, C Rory; Goodwin, Matthew L; Lo, Sheng-Fu Larry; Redmond, Kristin J; Tobert, Daniel G; Shin, John H; Ferrone, Marco L; Laufer, Ilya; Saifi, Comron; Buchowski, Jacob M; Jennings, Jack W; Ozturk, Ali K; Huang-Wright, Christina; Mesfin, Addisu; Steyn, Chris; Hsu, Wesley; Soliman, Hesham M; Krishnaney, Ajit A; Sciubba, Daniel M; Schwab, Joseph H; Colman, Matthew W.
Afiliação
  • Zavras AG; Rush University Medical Center, Department of Orthopaedic Surgery, United States.
  • Schoenfeld AJ; Brigham and Women's Hospital, Department of Orthopaedic Surgery, Harvard Medical School.
  • Patt JC; Carolinas Medical Center, Department of Orthopaedic Surgery, United States.
  • Munim MA; Rush University Medical Center, Department of Orthopaedic Surgery, United States.
  • Goodwin CR; Duke University Medical Center, Department of Neurosurgery, United States.
  • Goodwin ML; Washington University, Barnes-Jewish Hospital, Department of Orthopaedic Surgery, United States.
  • Lo SL; Johns Hopkins University School of Medicine, Department of Neurosurgery, United States.
  • Redmond KJ; Johns Hopkins University School of Medicine, Department of Radiation Oncology, United States.
  • Tobert DG; Massachusetts General Hospital, Department of Orthopaedic Surgery, Harvard Medical School, United States.
  • Shin JH; Massachusetts General Hospital, Department of Neurosurgery, Harvard Medical School, United States.
  • Ferrone ML; Brigham and Women's Hospital, Department of Orthopaedic Surgery, Harvard Medical School.
  • Laufer I; Memorial Sloan Kettering Cancer Center, Department of Neurosurgery.
  • Saifi C; University of Texas Southwestern, Department of Orthopaedic Surgery, United States.
  • Buchowski JM; Washington University School of Medicine, Department of Orthopaedic Surgery, United States.
  • Jennings JW; Washington University School of Medicine, Department of Radiology, United States.
  • Ozturk AK; Perelman School of Medicine, University of Pennsylvania, Department of Neurosurgery, United States.
  • Huang-Wright C; University Hospitals Cleveland Medical Center, Case Western Reserve University, Department of Neurological Surgery.
  • Mesfin A; University of Rochester, Department of Orthopaedic Surgery, United States.
  • Steyn C; McMaster University, Department of Orthopaedic Surgery.
  • Hsu W; Wake Forest University School of Medicine, Department of Neurological Surgery.
  • Soliman HM; Medical College of Wisconsin, Department of Neurosurgery.
  • Krishnaney AA; The Cleveland Clinic, Department of Neurosurgery.
  • Sciubba DM; Johns Hopkins University School of Medicine, Department of Neurosurgery, United States.
  • Schwab JH; Massachusetts General Hospital, Department of Orthopaedic Surgery, Harvard Medical School, United States.
  • Colman MW; Rush University Medical Center, Department of Orthopaedic Surgery, United States.
N Am Spine Soc J ; 10: 100105, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35368717
ABSTRACT

Background:

In spinal oncology, titanium implants pose several challenges including artifact on advanced imaging and therapeutic radiation perturbation. To mitigate these effects, there has been increased interest in radiolucent carbon fiber (CF) and CF-reinforced polyetheretherketone (CFR-PEEK) implants as an alternative for spinal reconstruction. This study surveyed the members of the North American Spine Society (NASS) section of Spinal Oncology to query their perspectives regarding the clinical utility, current practice patterns, and recommended future directions of radiolucent spinal implants.

Methods:

In February 2021, an anonymous survey was administered to the physicians of the NASS section of Spinal Oncology. Participation in the survey was optional. The survey contained 38 items including demographic questions as well as multiple-choice, yes/no questions, Likert rating scales, and short free-text responses pertaining to the "clinical concept", "efficacy", "problems/complications", "practice pattern", and "future directions" of radiolucent spinal implants.

Results:

Fifteen responses were received (71.4% response rate). Six of the participants (40%) were neurosurgeons, eight (53.3%) were orthopedic surgeons, and one was a spinal radiation oncologist. Overall, there were mixed opinions among the specialists. While several believed that radiolucent spinal implants provide substantial benefits for the detection of disease recurrence and radiation therapy options, others remained less convinced. Ongoing concerns included high costs, low availability, limited cervical and percutaneous options, and suboptimal screw and rod designs. As such, participants estimated that they currently utilize these implants for 27.3% of anterior and 14.7% of all posterior reconstructions after tumor resection.

Conclusion:

A survey of the NASS section of Spinal Oncology found a lack of consensus with regards to the imaging and radiation benefits, and several ongoing concerns about currently available options. Therefore, routine utilization of these implants for anterior and posterior spinal reconstructions remains low. Future investigations are warranted to practically validate these devices' theoretical risks and benefits.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: N Am Spine Soc J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: N Am Spine Soc J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos